Passive Heymann nephritis: Evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury

Experimental Nephrology

Volumn 4, Issue 4, 1996, Pages 213-221

  Zoja, Carla ^a,c   Corna, Daniela ^a   Bruzzi, Isabella ^a   Foglieni, Chiara ^a   Bertani, Tullio ^a,b   Remuzzi, Giuseppe ^a,b   Benigni, Ariela ^a  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c Laboratory of Kidney Diseases   (Italy)

Author keywords

Endothelin 1; Glomerulosclerosis; Passive Heymann nephritis; Perindopril; Proteinuria; Transforming growth factor ; Tubulointerstitial damage

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; PERINDOPRIL; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; ENZYME INHIBITION; GLOMERULOSCLEROSIS; HEYMANN NEPHRITIS; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIBODIES; BLOOD PRESSURE; CREATININE; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; INDOLES; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; PERINDOPRIL; PROTEINURIA; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0029768067     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 1990;38: 384-394.
2. Olson JL, Hostetter TH, Remke HG, Brenner BM, Venkalachalam MA: Allered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int 1982;22:112-126.
3. Bertani T, Zoja C, Abbate M, Rossini M, Remuzzi G: Age-relaled nephropathy and proteinuria in rats wilh intact kidneys exposed to diets with different protein contents. Lab Invest 1989;60:196-204.
4. Bertani T, Rocchi G, Sacchi G, Mecca G, Remuzzi G: Adriamycin-induced glomerulosclerosis in the rat. Am J Kidney Dis 1986;7: 12-19.
5. Glaser RJ, Velosa JA, Michaels AF: Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis. Lab Invest 1977;36:519-526.
6. Zoja C, Remuzzi A, Corna D, Perico N, Bertani T, Remuzzi G: Renal protective effect of angiotensin-converting enzyme inhibition in aging rats. Am J Med 1992;92(suppl 4B):60S-63S.
7. Anderson S, Meyer TW, Rennke HG, Brenner BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985;76:612-619.
8. Anderson S, Diamond JR, Karnovsky MJ, Brenner BM: Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. J Clin Invest 1988;82:1757-1768.
9. Feenstra K, van der Lee R, Greben HA, Arends A, Hoedemaeker PJ: Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. I. The natural history: A histological and immunohistologic study at the light microscopic and the ultrastructural level. Lab Invest 1975;32:235-242.
10. Kerjaschki D, Miettinen A, Farquhar MG: Initial events in the formation of immune deposits in passive Heymann nephritis. J Exp Med 1987;116:109-128.
11. Maezawa A, Ogiwara T, Matsui K, Suzuki Y, Nakamura T, Oite T, Shimizu F: Long-term observation of passive Heymann nephritis. Nephron 1985;41:348-353.
12. Okuda S, Oh Y, Tsuruda H, Onoyama K, Fujimi S, Omae T, Fujishima M: Rapidly progressive renal deterioration in partially nephrectomized rats with experimental membranous nephropathy. Nephron 1985;41:359-364.
13. D'Amico G: The clinical role of proteinuria. Am J Kidney Dis 1991;17:48-52.
14. Cameron JS: Proteinuria and progression in human glomerular diseases. Am J Nephrol 1990;10(suppl 1):81-87.
15. Perico N, Remuzzi G: Role of endothelin in glomerular injury. Kidney Int 1993;43(suppl 39):S76-S80.
16. Border WA, Noble NA: Transforming growth factor-β in tissue fibrosis. N Engl J Med 1994; 331:1286-1292.
17. Edgington TS, Glassock RJ, Watson JI, Dixon FJ: Characterization and isolation of specific renal tubular epithelial antigens. J Immunol 1967;99:1199-1210.
18. Pfeffer JM, Pfeffer MA, Frohlich ED: Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med 1971;78:957-962.
19. Bonsnes RW, Tausski HA: The colorimetric determination of creatinine of the Jaffé reaction. J Biol Chem 1945;158:581.
20. Read SM, Northcote DH: Minimization of variation in the response to different proteins of the Coomassie blue G dye-binding assay for protein. Anal Biochem 1981;116:53-64.
21. Benigni A, Perico N, Gaspari F, Zoja C, Bellizzi L, Gabanelli M, Remuzzi G: Increased renal endothelin production in rats with reduced re-nal mass. Am J Physiol 1991;260:F331-F339.
22. Wallenstein S, Zucker CL, Fleiss JL: Some statistical methods useful in circulation research. Circ Res 1980;47:1-9.
23. Okuda S, Oh Y, Tsuruda H, Onoyama K, Fujimi S, Fujishima M: Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int 1986;29:502-510.
24. Feenstra K, van der Lee R, Greben HA, Arends A, Hoedemaeker PJ: Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. II. Influence of medication with prednisone and azathioprine: A histologic and immunohistologic study at the light microscopic and the ultrastructural level. Lab Invest 1975;32:243-250.
25. Anderson S, Meyer TW, Brenner BM: The role of hemodynamic factors in the initiation and progression of renal disease. J Urol 1985;133: 363-368.
26. Fogo A, Yoshida Y, Glick AD, Homma T, Ichikawa I: Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis. J Clin Invest 1988;82:322-330.
27. Grond J, Schilthuis MS, Koudstaal J, Elema JD: Mesangial function and glomerular sclerosis in rats after unilateral nephrectomy. Kidney Int 1982;22:338-343.
28. Rennke HG, Klein PS: Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. Am J Kidney Dis 1989;13: 443-456.
29. Maack T, Park CH, Camargo MJF: Renal filtration, transport, and metabolism of proteins; in Seldin DW, Giebisch G (eds): The Kidney: Physiology and Pathophysiology. New York, Raven Press, 1985, pp 1773-1803.
30. Eddy AA, McCulloch L, Adams J, Liu E: Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 1989;135:719-733.
31. Kees-Folts D, Diamond JR: Infiltrating macrophages are a source of tubulointerstitial transforming growth factor-β in albumin-overload proteinuria (abstract). J Am Soc Nephrol 1994; 5:947.
32. Schreiner GF: The role of macrophage in glomerular injury. Semin Nephrol 1991;11:268-275.
33. Eddy AA: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria (abstract). J Am Soc Nephrol 1994;5:804.
34. Zoja C, Morigi M, Figliuzzi M, Bruzzi I, Benigni A, Ronco P, Remuzzi G: The renal toxicity of filtered proteins: Evidence that albumin stimulates endothelin-1 synthesis by proximal tubular epithelial cells in culture (abstract). J Am Soc Nephrol 1993;4:789.
35. Lundberg JM: Potent selective vasoconstrictor effects of endothelin in the pig kidney in vivo. Acta Physiol Scand 1988;134:573-574.
36. King AJ, Brenner BM, Anderson S: Endothelin: A potent renal and systemic vasoconstrictor peptide. Am J Physiol 1989;256:F1051-F1058.
37. Ong ACM, Jowett TP, Firth JD, Burton S, Kitamura M, Fine LG: A new paracrine loop implicated in human tubulo-interstitial fibrosis: Tubular-derived endothelins modulate renal interstitial fibroblast function (abstract). J Am Soc Nephrol 1993;4:473.
38. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986;77:1925-1930.
39. Lafayette RA, Mayer G, Park SK, Meyer TW: Angiotensin II blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 1992;90:766-771.
40. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of trans-forming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 1994;93: 2431-2437.
41. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G: Angiotensin-converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 1990;85: 541-549.
42. Orisio S, Benigni A, Bruzzi I, Corna D, Perico N, Zoja C, Benatti L, Remuzzi G: Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int 1993;43:354-358.
43. Benigni A, Zoja C, Corna D, Orisio S, Longaretti L, Bertani T, Remuzzi G: A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int 1993;44:440-444.
44. Border WA, Rouslahti E: Transforming growth factor-β in disease: The dark side of tissue repair. J Clin Invest 1992;90:1-7.
45. Okuda S, Languino LR, Ruoslahti E, Border WA: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 1990;86:453-462.
46. 1. Nature 1990;346: 371-374.
47. Border WA, Noble NA, Jamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-β protects against scarring in expeirmental kidney disease. Nature 1992;360: 361-364.
48. 1 in glomerulosclerosis and interstitial fibrosis of Adriamycin nephropathy. Kidney Int 1994;45: 525-536.
49. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor-β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 1993;90:1814-1818.
50. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J Clin Invest 1993;92: 2597-2601.
51. Kohno M, Horio T, Ikeda M, et al: Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells. Kidney Int 1992;42:860-866.
52. Abassi ZA, Klein H, Golomb E, Keiser HR: Regulation of the urinary excretion of endothelin in the rat. Am J Hypertens 1993;6:453-457.
53. Theuring F, Schmager F, Thone-Reinicke C, Chotzen S, Quertermous T, Schleuning W-D, Hocher B: Transgenic mice in endothelin research (abstract). Fourth International Conference on Endothelin, London, April 1995, p 146.
54. Paul M, Schonfelder G, Liefeldt L, Bocker W, Lippoldt A, Zintz M: Renal phenotype in transgenic rats expressing the human endothelin-2 gene (abstract). Fourth International Conference on Endothelin, London, April 1995, p 148.
55. 1 and progression of renal disease in the lisinopriltreated Fawn-Hooded rat (abstract). J Am Soc Nephrol 1994;5:804.
56. Keane WF, Mulcahy WS, Kasiske BL, Kim Y, O'Donnell MP: Hyperlipidemia and progressive renal disease. Kidney Int 1991;39(suppl 31):S41-S48.